telehealth.helpFind my match

Home Sermorelin FDA status

Is sermorelin FDA approved? Not anymore

No. Sermorelin was FDA-approved as Geref in 1990 and 1997, then its maker stopped selling it, and the approvals were withdrawn in 2009. The FDA found in 2013 that this was not for safety or effectiveness reasons. Today sermorelin in the US is compounded and needs a prescription.

  • FDA records checked
  • Primary sources: Federal Register, Drugs@FDA, FDA compounding lists

Sermorelin and the FDA: the record, date by date

DateWhat happenedSource
FDA approves Geref (sermorelin acetate) 0.05 mg, a diagnostic test of whether the pituitary can release growth hormone (NDA 19-863).Federal Register, 2013
FDA approves Geref 0.5 mg and 1.0 mg vials to treat idiopathic growth hormone deficiency in children with growth failure (NDA 20-443).Federal Register, 2013
EMD Serono tells the FDA it is discontinuing Geref (the diagnostic was discontinued in a July 11, 2008 letter).Federal Register, 2013
FDA withdrawal of both Geref approvals takes effect, at the company's request.Federal Register, 2013
FDA publishes its finding that Geref was "not withdrawn for reasons of safety or effectiveness", so a generic version could be approved if it meets the other rules.Federal Register, 2013
FDA's 503B nomination list (outsourcing facilities), latest update: sermorelin acetate is in Category 1, "under evaluation", and marked as a component of an FDA-approved drug.FDA 503B list
FDA's 503A nomination list (compounding pharmacies), latest update: sermorelin is not in any of its 3 categories.FDA 503A list
Drugs@FDA: the only sermorelin applications are the two Geref approvals (three strengths), all listed as discontinued. No generic has been approved.Drugs@FDA

Where to get compounded sermorelin with a prescription

Each program includes an online visit with a licensed clinician who decides whether sermorelin fits you. Of the 5 programs here, LevelsRx has the lowest monthly price, on its 12-month plan.

How we picked

Every program here is prescribed online by a US-licensed clinician, fills prescriptions through a licensed US pharmacy and lets you start without an office visit. Each card shows the price we read on the program's own site (or says when a program prices only after its intake) and what that price covers, and we keep the date of every read; some programs bill a membership and the medication separately, and the card says so. The label on each card says what that program stands out for. How we check prices and programs.

  1. Sermorelin or tesamorelin#1
    50% off your first month (6-month plan)

    Growth hormone peptides from $199.99 a month

    • Compounded sermorelin or tesamorelin from LegitScript-certified US pharmacies
    • Physician-led care team; message your doctor anytime
    • IGF-1 testing before and after; free temperature-safe shipping

    Comes asVial

    From$199.99/moon the 6-month plan; $299.99 for 1 month
    4.4 on Trustpilot1,106 reviews ·
    Visit Maximus Read our Maximus review
  2. Lowest monthly price#2

    Sermorelin from $89 a month on the 12-month plan

    • $109/mo on 6 months, $149/mo on 3 months
    • Free shipping on every order, automatic refills
    • 24/7 access to a clinician

    Comes asInjection

    From$89/moon the 12-month plan; $250 for a single month
    Visit LevelsRx Read our LevelsRx review
  3. Money-back guarantee#3
    Special offer: 33% off

    Sermorelin from $129 a month, no hidden fees

    • Nightly injection; your provider reviews bloodwork, history and goals
    • Full refund if a clinician says it isn't right for you
    • $149 for 1 month or $139/mo on 3 months

    Comes asInjection

    From$129/moon the 6-month plan; $149 for 1 month
    Visit Enhanced Read our Enhanced review
  4. Best rated#4
    First month $30 less

    Lab-tested sermorelin with coaching and meal plans

    • Third-party lab tested for potency, sterility, pH and endotoxins
    • Personal protocol, coaching and unlimited physician messaging
    • Free shipping; month to month $195 the first month, then $225

    Comes asVial or under the tongue

    First month from$155/moquarterly plan paid up front, then $185/mo
    4.7 on Trustpilot1,179 reviews ·
    Visit ReadyRx Read our ReadyRx review
  5. Lowest first month#5
    Pre-Black Friday sale: $100 off

    Sermorelin for $49 the first month, then $99

    • Doctor visit, prescription and free fast shipping from a licensed US pharmacy
    • No insurance or bloodwork required; refund if you are not eligible
    • Month to month, cancel anytime

    Comes asInjection

    First month$49/mopre-Black Friday sale, then $99/mo month to month
    Visit Embody

What "compounded" means for sermorelin today

With no approved product on the market, sermorelin reaches patients through compounding pharmacies. The FDA's own wording is plain: "Compounded drugs are not FDA-approved." That means the FDA does not check a compounded drug's safety, effectiveness or quality before it is sold.

Federal law (section 503A of the Food, Drug, and Cosmetic Act) lets a licensed pharmacy compound a drug "for an identified individual patient based on the receipt of a valid prescription order". The ingredient must meet one of three tests: it has a USP or NF monograph, it is a component of an FDA-approved drug, or it is on the FDA's 503A list. Sermorelin is not on the FDA's 503A nomination list (May 14, 2026). On its 503B list for outsourcing facilities (March 21, 2025), the FDA lists sermorelin acetate in Category 1, under evaluation, and marks it as a component of an FDA-approved drug (Geref).

Sources: FDA, Compounding and the FDA; 21 U.S.C. 353a; FDA 503A nominated substances; FDA 503B nominated substances.

Sermorelin vs other growth hormone boosters and the FDA

Tesamorelin: approved for one use

Tesamorelin is FDA-approved as Egrifta SV "for the reduction of excess abdominal fat in HIV-infected adult patients with lipodystrophy". Its label adds that it is not for weight loss. Maximus sells compounded tesamorelin alongside sermorelin.

Source: Egrifta SV label, DailyMed.

Ibutamoren: flagged by the FDA

Ibutamoren mesylate sits in Category 2 of the FDA's 503A list: substances that "raise significant safety risks" in compounding. Sermorelin is not on that list.

Source: FDA 503A nominated substances, May 14, 2026.

More on sermorelin: sermorelin in our wiki, all sermorelin programs compared, sermorelin prices side by side and online longevity programs.

Sermorelin and the FDA: questions

Is sermorelin FDA approved?

Not today. The FDA approved it as Geref in 1990 (a diagnostic test) and 1997 (growth hormone deficiency in children). The maker stopped selling it in 2008, and the approvals were withdrawn effective June 18, 2009. There is no FDA-approved sermorelin product on the market now.

Why was sermorelin taken off the market?

The maker, EMD Serono, discontinued it and asked the FDA to withdraw the approvals. In 2013 the FDA reviewed its records and the medical literature and found Geref was not withdrawn for reasons of safety or effectiveness.

Do you need a prescription for sermorelin?

Yes. Sermorelin sold in the US today is compounded, and federal law allows a pharmacy to compound a drug like this for an identified patient based on a valid prescription. The online programs here include the clinician visit that writes it.

Is compounded sermorelin legal?

Sermorelin is compounded on prescription today. It is not on the FDA's list of substances that raise significant safety risks, where substances such as ibutamoren mesylate sit. On the FDA's 503B list, sermorelin acetate is under evaluation. Compounded drugs are not FDA-approved, so the FDA has not checked their safety, effectiveness or quality before sale.

Is there an FDA-approved alternative to sermorelin?

Tesamorelin, another growth hormone-releasing peptide, is FDA-approved as Egrifta SV, but only to reduce excess belly fat in adults with HIV and lipodystrophy. Ask a clinician which, if any, fits you.

See sermorelin programs